{"id":"https://openalex.org/W4361908992","doi":"https://doi.org/10.1158/1078-0432.22451769","title":"Supplementary Tables 1 - 2 from Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors","display_name":"Supplementary Tables 1 - 2 from Safety and Pharmacokinetics of Ganitumab (AMG 479) Combined with Sorafenib, Panitumumab, Erlotinib, or Gemcitabine in Patients with Advanced Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908992","doi":"https://doi.org/10.1158/1078-0432.22451769"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451769","doi":"https://doi.org/10.1158/1078-0432.22451769","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451769","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_2_from_Safety_and_Pharmacokinetics_of_Ganitumab_AMG_479_Combined_with_Sorafenib_Panitumumab_Erlotinib_or_Gemcitabine_in_Patients_with_Advanced_Solid_Tumors/22451769/1/files/39902844.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_2_from_Safety_and_Pharmacokinetics_of_Ganitumab_AMG_479_Combined_with_Sorafenib_Panitumumab_Erlotinib_or_Gemcitabine_in_Patients_with_Advanced_Solid_Tumors/22451769/1/files/39902844.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037497042","display_name":"Lee S. Rosen","orcid":"https://orcid.org/0000-0003-2503-6133","observed_orcids":["https://orcid.org/0000-0003-2503-6133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee S. Rosen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042578919","display_name":"Gregory R. Friberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory Friberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088841234","display_name":"Emily W. Chan","orcid":"https://orcid.org/0000-0001-9458-3080","observed_orcids":["https://orcid.org/0000-0001-9458-3080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111601794","display_name":"Yuying C. Hwang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuying C. Hwang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063058991","display_name":"Hongjie Deng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongjie Deng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106038439","display_name":"Jill Gilbert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Gilbert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004814161","display_name":"Devalingam Mahalingam","orcid":"https://orcid.org/0000-0002-2979-9894","observed_orcids":["https://orcid.org/0000-0002-2979-9894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Devalingam Mahalingam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059195446","display_name":"Ian McCaffery","orcid":"https://orcid.org/0000-0002-6697-0961","observed_orcids":["https://orcid.org/0000-0002-6697-0961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian McCaffery","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048189443","display_name":"Shaunita A. Michael","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaunita A. Michael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000961519","display_name":"Alain C. Mita","orcid":"https://orcid.org/0009-0009-3260-4793","observed_orcids":["https://orcid.org/0009-0009-3260-4793","https://orcid.org/0000-0002-5387-0160"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alain C. Mita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109341340","display_name":"Monica M Mita","orcid":"https://orcid.org/0009-0004-8448-4854","observed_orcids":["https://orcid.org/0009-0004-8448-4854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica M. Mita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112047718","display_name":"Marilyn Mulay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marilyn Mulay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061549439","display_name":"Poornima Shubhakar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Poornima Shubhakar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100643920","display_name":"Min Zhu","orcid":"https://orcid.org/0000-0002-0009-0662","observed_orcids":["https://orcid.org/0000-0002-0009-0662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057503413","display_name":"John Sarantopoulos","orcid":"https://orcid.org/0009-0002-4395-136X","observed_orcids":["https://orcid.org/0009-0002-4395-136X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Sarantopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5985999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5985999703407288,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.14509999752044678,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.10249999910593033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganitumab","display_name":"ganitumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.6510000228881836},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":1.0},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.824999988079071},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.5669999718666077},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pten-expression","display_name":"PTEN expression","score":0.9769999980926514}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.7261021733283997},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7047027945518494},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6705797910690308},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6288163661956787},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5789839029312134},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.553900957107544},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45824524760246277},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4047470688819885},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40371769666671753},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.33929765224456787},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.14899730682373047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13153347373008728},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.08649563789367676},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0631418526172638}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22451769","doi":"https://doi.org/10.1158/1078-0432.22451769","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451769","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_2_from_Safety_and_Pharmacokinetics_of_Ganitumab_AMG_479_Combined_with_Sorafenib_Panitumumab_Erlotinib_or_Gemcitabine_in_Patients_with_Advanced_Solid_Tumors/22451769/1/files/39902844.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22451769.v1","doi":"https://doi.org/10.1158/1078-0432.22451769.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22451769.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451769","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_2_from_Safety_and_Pharmacokinetics_of_Ganitumab_AMG_479_Combined_with_Sorafenib_Panitumumab_Erlotinib_or_Gemcitabine_in_Patients_with_Advanced_Solid_Tumors/22451769","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451769","doi":"https://doi.org/10.1158/1078-0432.22451769","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451769","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Tables_1_-_2_from_Safety_and_Pharmacokinetics_of_Ganitumab_AMG_479_Combined_with_Sorafenib_Panitumumab_Erlotinib_or_Gemcitabine_in_Patients_with_Advanced_Solid_Tumors/22451769/1/files/39902844.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908992.pdf","grobid_xml":"https://content.openalex.org/works/W4361908992.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133676982","https://openalex.org/W4361951501","https://openalex.org/W1987650637","https://openalex.org/W2065879591","https://openalex.org/W2231490115","https://openalex.org/W4361920091","https://openalex.org/W2241286838","https://openalex.org/W2144824249","https://openalex.org/W2526289992","https://openalex.org/W2246205454"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"93KB,":[2],"Supplemental":[3,9],"Table":[4,10],"1.":[5],"Study":[6],"Drug":[7],"Administration;":[8],"2.":[11],"Summary":[12],"of":[13],"Somatic":[14],"Mutation":[15],"Status":[16],"and":[17],"Tumor":[18,26],"PTEN":[19],"Expression":[20],"Versus":[21],"Best":[22],"Result":[23],"Change":[24],"in":[25],"Dimensions.":[27]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}